Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now IOB - Delayed Quote • EUR Innate Pharma S.A. (0EVI.IL) Follow Add holdings 1.7720 +0.0080 +(0.45%) At close: 2:52:34 PM GMT+1 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 0EVI.IL 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 0EVI.IL View More All News Press Releases SEC Filings French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit Innate Pharma Announces €15M Investment by Sanofi Sanofi to Invest $17.2 Million in Innate Pharma as Part of Review of 2016 License Agreement Innate Pharma Regains Its Rights on CD123 Targeting ANKET® and Announces Sanofi’s Intention to Make a Strategic Investment in the Company Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum European Penny Stocks To Watch In March 2025 Innate Pharma SA (IPHA) (FY 2024) Earnings Call Highlights: Strategic Advances and Financial ... Innate Pharma Reports Full Year 2024 Financial Results and Business Update Innate Pharma Highlights Antibody Drug Conjugate IPH4502 Abstract Selected for the AACR 2025 Annual Meeting